MILIP and nonpapillary renal cell carcinoma: Regardless, the results presented here demonstrate a signaling pathway encompassing TFAP2C, MILIP, YBX1 and Snai1 that promotes ccRCC metastasis and propose that MILIP may constitute a molecular target for treatment of late-stage ccRCC (Supplementary Fig. 6).